BioSpace News Archive

Business

Xcell Biosciences Announces New Emphasis Towards Immunotherapy Markets and Expands Leadership Team

Xcell Biosciences announced today that it has expanded its development and commercial efforts around new market opportunities in immunotherapy drug research and development.

January 4, 2018
·
2 min read
Acticor Biotech Announces the Closing of a €1.7 Million Equity Financing Led by Primer Capital

Acticor Biotech is strengthening its cash position in the perspective of the preparation of the first clinical phase II for its lead candidate, ACT017.

January 4, 2018
·
2 min read
Drug Development

Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity

Final protocol confirmed for pivotal Phase 3 clinical trial in pro-opiomelanocortin (POMC) deficiency obesity,

January 4, 2018
·
7 min read
Business

HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance

Total revenue for the fourth quarter of 2017 is expected to be between $6.9 and $7.2 million, an increase of 373% to 394% over the fourth quarter of 2016.

January 4, 2018
·
6 min read
Drug Development

Catalyst Biosciences Initiates Phase II/III Trial of Marzeptacog Alfa (activated) for Prophylaxis in Hemophilia A or B With Inhibitors

This Phase 2 open-label, subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors will evaluate the ability of MarzAA to eliminate, or minimize, spontaneous bleeding episodes.

January 4, 2018
·
4 min read
Drug Development

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress

A look at the accomplishments that occurred during the fourth quarter of 2017.

January 4, 2018
·
8 min read
BioMidwest

PTS Diagnostics Announces New Retail Point-of-Care Software

Unlike other data capture systems, PTS Connect ProLink delivers a personalized wellness report through wireless technology.

January 4, 2018
·
3 min read
Drug Development

Adverum Biotechnologies Provides 2018 Outlook

Accelerating pipeline development in 2018 after transforming into clinical-stage company in 2017.

January 4, 2018
·
5 min read
Drug Development

Auris Medical Provides Update on AM-111 Development Program

Further analyses on the basis of the full data set provide additional confirmation of and support for AM-111’s otoprotective effects in the profound acute hearing loss subpopulation.

January 4, 2018
·
7 min read
Business

EyeGate Promotes Sarah Romano to Chief Financial Officer

Sarah Romano, elevated from Interim CFO, will lead finance effort during transition to commercialization phase.

January 4, 2018
·
4 min read